secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001824293-26-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio increases ATM offering capacity to $7.38M, waives Dec 2025 SPA restrictions
--------------------------------------------------------------------------------

- Increased ATM capacity by up to $7.38M in common stock; $6.17M already sold under the program.
- Waived certain provisions of the Dec 11, 2025 securities purchase agreement to permit additional ATM issuances.
- At-the-market offering agreement with H.C. Wainwright & Co. dated May 20, 2024 remains in effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/0001824293-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/val-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001824293-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer